Skip to content

Clarivate

US · CLVT #3290 by market cap
1.47 -0.01 -0.34%
Live - 5344 symbols - heartbeat 207s ago · 2026-10-08 09:55
Pre-market 1.47 0.00%
After-hours 1.46 -0.68%
Market cap
937.11M
P/B
0.21
EPS
-0.30
Reader sentiment Are you bullish or bearish on CLVT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.5 percentage points.

Institutional ownership

Held by institutions
108.58% -0.49pp
Institutions
290 -3
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund45.93%
VC/PE Fund38.26%
Family Office/Trust15.90%
Hedge Fund4.73%
Individual/Insider2.58%
Government Pension Fund1.76%
Public Company1.49%
Private Company0.34%
Insurance Company0.15%

Top holders as of 2026-06-30

Leonard Green & Partners, L.P. 18.24% · 116.67M sh
Lingotto Investment Management LLP 10.52% · 67.29M sh
Clarkston Capital Partners, LLC 7.15% · 45.73M sh
Castik Capital Partners GmbH 5.95% · 38.09M sh
BlackRock 4.87% · 31.15M sh
Partners Group Holding AG 4.00% · 25.58M sh
Fidelity International Ltd 3.95% · 25.27M sh
Onex Corporation 3.86% · 24.69M sh
Cambridge Information Group, Inc. 3.61% · 23.11M sh
Atairos Management, L.P. 3.52% · 22.49M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 23 sells

NameRoleStake
Leonard Green & Partners, L.P. -- 18.24%
Simon Webster President of Intellectual Property 0.72%
Matitiahu Shem Tov Chief Executive Officer 0.41%
Kenneth Cornick Director 0.32%
Gordon Samson President of Intellectual Property 0.16%
Henry Levy President of Life Sciences & Healthcare 0.15%
Michael Easton Senior VP of Finance & Chief Accounting Officer 0.14%
William Graff Chief Information Officer 0.13%
Bar Veinstein President of Academia & Government 0.08%
Andrew Snyder Independent Non-Executive Chairperson 0.08%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Andrew Snyder Independent Non-Executive Chairperson Sale to Issuer -1,012 $1.67
2026-09-29 Andrew Snyder Independent Non-Executive Chairperson Other Acquisition +30,688 $1.67
2026-09-29 Jane Bomba Independent Director Sale to Issuer -181 $1.67
2026-09-29 Jane Bomba Independent Director Other Acquisition +17,215 $1.67
2026-09-29 Kenneth Cornick Director Sale to Issuer -3,444 $1.67
2026-09-29 Kenneth Cornick Director Other Acquisition +17,215 $1.67
2026-08-14 Michael Easton Senior VP of Finance & Chief Accounting Officer Other Acquisition +194,300 --
2026-08-14 Matthew Lisowski Chief Accounting Officer Other Acquisition +67,357 --
2026-08-12 Matitiahu Shem Tov Chief Executive Officer Sale to Issuer -47,633 $1.96
2026-08-07 Matthew Lisowski Chief Accounting Officer Initial Statement of Beneficial 0 --
2026-08-06 Kenneth Cornick Director Open Market Acquisition +900,000 $1.85–1.86
2026-08-02 Cambridge Information Group, Inc. -- Open Market Disposition -2,489,618 $1.94
2026-06-29 Andrew Snyder Independent Non-Executive Chairperson Sale to Issuer -1,513 $2.16
2026-06-29 Andrew Snyder Independent Non-Executive Chairperson Other Acquisition +23,726 $2.16
2026-06-29 Jane Bomba Independent Director Sale to Issuer -386 $2.16
2026-06-29 Jane Bomba Independent Director Other Acquisition +13,310 $2.16
2026-06-29 Kenneth Cornick Director Sale to Issuer -2,662 $2.16
2026-06-29 Kenneth Cornick Director Other Acquisition +13,310 $2.16
2026-06-14 Simon Webster President of Intellectual Property Other Acquisition +396,825 --
2026-06-09 Simon Webster President of Intellectual Property Initial Statement of Beneficial 0 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 09:55:30 · For reference only, not investment advice and not tailored to your situation.